Skip to content
10-K

Annual Report

Neurotrope, Inc.

0001104659-20-033198

← back to feed
Filed
Mar 13, 2020 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2019 · Feb 20, 2020 19.75M sh
Capex FY 2019 · Dec 31, 2019 $5.21K
Capex FY 2019 · Dec 31, 2018 $3.19K
Operating Cash Flow FY 2019 · Dec 31, 2019 −$11.89M
Operating Cash Flow FY 2019 · Dec 31, 2018 −$7.7M
Cash And Equivalents FY 2019 · Dec 31, 2019 $17.38M
Cash And Equivalents FY 2019 · Dec 31, 2018 $28.85M
Cash And Equivalents FY 2019 · Dec 31, 2017 $16.11M
Stockholders Equity FY 2019 · Dec 31, 2019 $17.42M
Stockholders Equity FY 2019 · Dec 31, 2018 $26.52M
Stockholders Equity FY 2019 · Dec 31, 2017 $14.89M
Current Liabilities FY 2019 · Dec 31, 2019 $479.06K
Current Liabilities FY 2019 · Dec 31, 2018 $2.96M
Current Assets FY 2019 · Dec 31, 2019 $17.88M
Current Assets FY 2019 · Dec 31, 2018 $29.46M
Total Assets FY 2019 · Dec 31, 2019 $17.9M
Total Assets FY 2019 · Dec 31, 2018 $29.48M
Sga Expense FY 2019 · Dec 31, 2019 $6.74M
Sga Expense FY 2019 · Dec 31, 2018 $4M
Rd Expense FY 2019 · Dec 31, 2019 $4.54M
Rd Expense FY 2019 · Dec 31, 2018 $4.62M
Net Income FY 2019 · Dec 31, 2019 −$15.13M
Net Income FY 2019 · Dec 31, 2018 −$11.02M